K-Ras G12C-IN-4(Cat No.:I017826)is a covalent small-molecule inhibitor designed to selectively target the K-Ras G12C mutant, a common oncogenic driver in non-small cell lung cancer (NSCLC) and other solid tumors. It binds irreversibly to the mutant cysteine at position 12, locking K-Ras in its inactive GDP-bound state and preventing downstream MAPK/ERK signaling. This blockade suppresses tumor cell proliferation and survival, making it a promising therapeutic lead. K-Ras G12C-IN-4 is widely used in cancer research to investigate precision medicine approaches for Ras-driven malignancies.